rs772645133

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_001387283.1(SMARCA4):​c.4250G>A​(p.Cys1417Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000111 in 1,447,378 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C1417S) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

SMARCA4
NM_001387283.1 missense

Scores

4
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -0.105

Publications

0 publications found
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
  • intellectual disability, autosomal dominant 16
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rhabdoid tumor predisposition syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • uterine corpus sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.12674248).
BP6
Variant 19-11039537-G-A is Benign according to our data. Variant chr19-11039537-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 480647.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA4NM_001387283.1 linkc.4250G>A p.Cys1417Tyr missense_variant Exon 30 of 36 ENST00000646693.2 NP_001374212.1
SMARCA4NM_003072.5 linkc.4171-1770G>A intron_variant Intron 29 of 34 ENST00000344626.10 NP_003063.2 P51532-1A7E2E1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA4ENST00000646693.2 linkc.4250G>A p.Cys1417Tyr missense_variant Exon 30 of 36 NM_001387283.1 ENSP00000495368.1 Q9HBD4
SMARCA4ENST00000643549.1 linkc.4151G>A p.Cys1384Tyr missense_variant Exon 29 of 35 ENSP00000493975.1 A0A2R8Y4P4
SMARCA4ENST00000344626.10 linkc.4171-1770G>A intron_variant Intron 29 of 34 1 NM_003072.5 ENSP00000343896.4 P51532-1
SMARCA4ENST00000541122.6 linkc.4072-1761G>A intron_variant Intron 29 of 34 5 ENSP00000445036.2 P51532-4
SMARCA4ENST00000643296.1 linkc.4072-1761G>A intron_variant Intron 28 of 33 ENSP00000496635.1 P51532-4
SMARCA4ENST00000644737.1 linkc.4072-1761G>A intron_variant Intron 28 of 33 ENSP00000495548.1 P51532-4
SMARCA4ENST00000589677.5 linkc.4072-1761G>A intron_variant Intron 29 of 34 5 ENSP00000464778.1 P51532-3
SMARCA4ENST00000643995.1 linkc.3583-1761G>A intron_variant Intron 26 of 31 ENSP00000496004.1 A0A2R8YGG3
SMARCA4ENST00000644963.1 linkc.2815-1761G>A intron_variant Intron 22 of 27 ENSP00000495599.1 A0A2R8YG32
SMARCA4ENST00000644065.1 linkc.2797-1761G>A intron_variant Intron 21 of 26 ENSP00000493615.1 A0A2R8Y440
SMARCA4ENST00000642350.1 linkc.2656-1761G>A intron_variant Intron 21 of 26 ENSP00000495355.1 A0A2R8Y6N0
SMARCA4ENST00000643857.1 linkc.2524-1761G>A intron_variant Intron 20 of 24 ENSP00000494159.1 A0A2R8Y526
SMARCA4ENST00000538456.4 linkc.328-1761G>A intron_variant Intron 3 of 7 3 ENSP00000495197.1 A0A2R8YFK5

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000435
AC:
1
AN:
229956
AF XY:
0.00000794
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000179
GnomAD4 exome
AF:
0.0000111
AC:
16
AN:
1447378
Hom.:
0
Cov.:
28
AF XY:
0.00000973
AC XY:
7
AN XY:
719656
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32606
American (AMR)
AF:
0.00
AC:
0
AN:
42100
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25898
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38848
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83338
European-Finnish (FIN)
AF:
0.0000188
AC:
1
AN:
53178
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5712
European-Non Finnish (NFE)
AF:
0.0000136
AC:
15
AN:
1105888
Other (OTH)
AF:
0.00
AC:
0
AN:
59810
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.00000830
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Rhabdoid tumor predisposition syndrome 2 Uncertain:1
Jul 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 1417 of the SMARCA4 protein (p.Cys1417Tyr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 480647). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Hereditary cancer-predisposing syndrome Benign:1
Oct 24, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0091
.;T;.;.;T
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.0027
N
LIST_S2
Benign
0.66
T;.;.;T;T
M_CAP
Uncertain
0.23
D
MetaRNN
Benign
0.13
T;T;T;T;T
MetaSVM
Benign
-0.69
T
PhyloP100
-0.10
PrimateAI
Uncertain
0.61
T
Sift4G
Uncertain
0.038
.;.;.;.;D
Polyphen
0.68
.;P;.;.;P
Vest4
0.20
MutPred
0.29
.;Gain of methylation at K1422 (P = 0.0629);.;.;Gain of methylation at K1422 (P = 0.0629);
MVP
0.11
ClinPred
0.20
T
GERP RS
-0.52
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs772645133; hg19: chr19-11150213; API